JP2005532034A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005532034A5 JP2005532034A5 JP2003556442A JP2003556442A JP2005532034A5 JP 2005532034 A5 JP2005532034 A5 JP 2005532034A5 JP 2003556442 A JP2003556442 A JP 2003556442A JP 2003556442 A JP2003556442 A JP 2003556442A JP 2005532034 A5 JP2005532034 A5 JP 2005532034A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- polypeptide
- nucleic acid
- diseases
- acid molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229920001184 polypeptide Polymers 0.000 claims 27
- 102000004196 processed proteins & peptides Human genes 0.000 claims 27
- 108090000765 processed proteins & peptides Proteins 0.000 claims 27
- 150000007523 nucleic acids Chemical class 0.000 claims 25
- 108020004707 nucleic acids Proteins 0.000 claims 24
- 102000039446 nucleic acids Human genes 0.000 claims 24
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 23
- 201000010099 disease Diseases 0.000 claims 22
- 208000015181 infectious disease Diseases 0.000 claims 8
- 238000000034 method Methods 0.000 claims 8
- 239000000523 sample Substances 0.000 claims 7
- 150000001875 compounds Chemical class 0.000 claims 6
- 230000000694 effects Effects 0.000 claims 6
- 210000004027 cell Anatomy 0.000 claims 5
- 239000013068 control sample Substances 0.000 claims 5
- 208000035143 Bacterial infection Diseases 0.000 claims 4
- 208000024172 Cardiovascular disease Diseases 0.000 claims 4
- 208000011231 Crohn disease Diseases 0.000 claims 4
- 208000019693 Lung disease Diseases 0.000 claims 4
- 206010040070 Septic Shock Diseases 0.000 claims 4
- 208000006011 Stroke Diseases 0.000 claims 4
- 208000022362 bacterial infectious disease Diseases 0.000 claims 4
- 208000014951 hematologic disease Diseases 0.000 claims 4
- 208000027866 inflammatory disease Diseases 0.000 claims 4
- 201000002364 leukopenia Diseases 0.000 claims 4
- 231100001022 leukopenia Toxicity 0.000 claims 4
- 201000001441 melanoma Diseases 0.000 claims 4
- 230000001613 neoplastic effect Effects 0.000 claims 4
- 210000001519 tissue Anatomy 0.000 claims 4
- 230000029663 wound healing Effects 0.000 claims 4
- 208000023275 Autoimmune disease Diseases 0.000 claims 3
- 230000001684 chronic effect Effects 0.000 claims 3
- 238000003745 diagnosis Methods 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 239000012634 fragment Substances 0.000 claims 3
- 208000026278 immune system disease Diseases 0.000 claims 3
- 201000001119 neuropathy Diseases 0.000 claims 3
- 230000007823 neuropathy Effects 0.000 claims 3
- 239000013610 patient sample Substances 0.000 claims 3
- 208000033808 peripheral neuropathy Diseases 0.000 claims 3
- 208000030507 AIDS Diseases 0.000 claims 2
- 208000012124 AIDS-related disease Diseases 0.000 claims 2
- 206010002556 Ankylosing Spondylitis Diseases 0.000 claims 2
- 201000001320 Atherosclerosis Diseases 0.000 claims 2
- 208000009137 Behcet syndrome Diseases 0.000 claims 2
- 208000019838 Blood disease Diseases 0.000 claims 2
- 206010010741 Conjunctivitis Diseases 0.000 claims 2
- 241000701022 Cytomegalovirus Species 0.000 claims 2
- 208000005189 Embolism Diseases 0.000 claims 2
- 201000009273 Endometriosis Diseases 0.000 claims 2
- 206010017533 Fungal infection Diseases 0.000 claims 2
- 206010018364 Glomerulonephritis Diseases 0.000 claims 2
- 201000005569 Gout Diseases 0.000 claims 2
- 208000009329 Graft vs Host Disease Diseases 0.000 claims 2
- 206010019280 Heart failures Diseases 0.000 claims 2
- 208000031226 Hyperlipidaemia Diseases 0.000 claims 2
- 206010020751 Hypersensitivity Diseases 0.000 claims 2
- 206010061216 Infarction Diseases 0.000 claims 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 2
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 2
- 208000007466 Male Infertility Diseases 0.000 claims 2
- 241001465754 Metazoa Species 0.000 claims 2
- 208000000112 Myalgia Diseases 0.000 claims 2
- 208000031888 Mycoses Diseases 0.000 claims 2
- 208000014767 Myeloproliferative disease Diseases 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 108020004711 Nucleic Acid Probes Proteins 0.000 claims 2
- 208000008589 Obesity Diseases 0.000 claims 2
- 208000001132 Osteoporosis Diseases 0.000 claims 2
- 206010033645 Pancreatitis Diseases 0.000 claims 2
- 201000004681 Psoriasis Diseases 0.000 claims 2
- 206010063837 Reperfusion injury Diseases 0.000 claims 2
- 206010039491 Sarcoma Diseases 0.000 claims 2
- 206010040047 Sepsis Diseases 0.000 claims 2
- 208000001435 Thromboembolism Diseases 0.000 claims 2
- 208000007536 Thrombosis Diseases 0.000 claims 2
- 206010046851 Uveitis Diseases 0.000 claims 2
- 208000036142 Viral infection Diseases 0.000 claims 2
- 208000010399 Wasting Syndrome Diseases 0.000 claims 2
- 230000032683 aging Effects 0.000 claims 2
- 230000007815 allergy Effects 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 208000007502 anemia Diseases 0.000 claims 2
- 208000006673 asthma Diseases 0.000 claims 2
- 230000001363 autoimmune Effects 0.000 claims 2
- 238000009739 binding Methods 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 claims 2
- 208000015322 bone marrow disease Diseases 0.000 claims 2
- 238000010322 bone marrow transplantation Methods 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 208000029742 colonic neoplasm Diseases 0.000 claims 2
- 230000002281 colonystimulating effect Effects 0.000 claims 2
- 238000001514 detection method Methods 0.000 claims 2
- 230000009547 development abnormality Effects 0.000 claims 2
- 206010012601 diabetes mellitus Diseases 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 230000003073 embolic effect Effects 0.000 claims 2
- 208000024908 graft versus host disease Diseases 0.000 claims 2
- 210000003714 granulocyte Anatomy 0.000 claims 2
- 208000018706 hematopoietic system disease Diseases 0.000 claims 2
- 230000009390 immune abnormality Effects 0.000 claims 2
- 230000007574 infarction Effects 0.000 claims 2
- 208000028867 ischemia Diseases 0.000 claims 2
- 208000032839 leukemia Diseases 0.000 claims 2
- 208000013104 leukocyte disease Diseases 0.000 claims 2
- 208000019423 liver disease Diseases 0.000 claims 2
- 201000004792 malaria Diseases 0.000 claims 2
- 230000006371 metabolic abnormality Effects 0.000 claims 2
- 238000012544 monitoring process Methods 0.000 claims 2
- 201000006417 multiple sclerosis Diseases 0.000 claims 2
- 206010028417 myasthenia gravis Diseases 0.000 claims 2
- 208000031225 myocardial ischemia Diseases 0.000 claims 2
- 239000002853 nucleic acid probe Substances 0.000 claims 2
- 235000020824 obesity Nutrition 0.000 claims 2
- 201000008482 osteoarthritis Diseases 0.000 claims 2
- 230000001575 pathological effect Effects 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 230000002062 proliferating effect Effects 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 2
- 206010039083 rhinitis Diseases 0.000 claims 2
- 230000036303 septic shock Effects 0.000 claims 2
- 208000017520 skin disease Diseases 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 2
- 230000009261 transgenic effect Effects 0.000 claims 2
- 241001529453 unidentified herpesvirus Species 0.000 claims 2
- 208000019553 vascular disease Diseases 0.000 claims 2
- 230000009385 viral infection Effects 0.000 claims 2
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 claims 1
- 208000031295 Animal disease Diseases 0.000 claims 1
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 206010064147 Gastrointestinal inflammation Diseases 0.000 claims 1
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 claims 1
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 claims 1
- 208000017604 Hodgkin disease Diseases 0.000 claims 1
- 208000010747 Hodgkins lymphoma Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 208000012902 Nervous system disease Diseases 0.000 claims 1
- 208000025966 Neurological disease Diseases 0.000 claims 1
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 208000030852 Parasitic disease Diseases 0.000 claims 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 claims 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 claims 1
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 claims 1
- 206010068956 Respiratory tract inflammation Diseases 0.000 claims 1
- 102000040739 Secretory proteins Human genes 0.000 claims 1
- 108091058545 Secretory proteins Proteins 0.000 claims 1
- 208000025865 Ulcer Diseases 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- 208000037883 airway inflammation Diseases 0.000 claims 1
- 125000000539 amino acid group Chemical group 0.000 claims 1
- 230000003321 amplification Effects 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 239000012472 biological sample Substances 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 206010009887 colitis Diseases 0.000 claims 1
- 239000002299 complementary DNA Substances 0.000 claims 1
- 210000002249 digestive system Anatomy 0.000 claims 1
- 230000009429 distress Effects 0.000 claims 1
- 208000006575 hypertriglyceridemia Diseases 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 239000003446 ligand Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 238000003199 nucleic acid amplification method Methods 0.000 claims 1
- 230000036281 parasite infection Effects 0.000 claims 1
- 230000004952 protein activity Effects 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 230000029058 respiratory gaseous exchange Effects 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
- 230000003248 secreting effect Effects 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0130720.6A GB0130720D0 (en) | 2001-12-21 | 2001-12-21 | Proteins |
| PCT/GB2002/005890 WO2003055912A2 (en) | 2001-12-21 | 2002-12-23 | Secreted proteins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005532034A JP2005532034A (ja) | 2005-10-27 |
| JP2005532034A5 true JP2005532034A5 (cg-RX-API-DMAC7.html) | 2006-02-16 |
Family
ID=9928221
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003556442A Abandoned JP2005532034A (ja) | 2001-12-21 | 2002-12-23 | 分泌タンパク質 |
| JP2003554728A Abandoned JP2005528083A (ja) | 2001-12-21 | 2002-12-23 | レプチンタンパク質 |
| JP2003556443A Abandoned JP2005528086A (ja) | 2001-12-21 | 2002-12-23 | 分泌タンパク質 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003554728A Abandoned JP2005528083A (ja) | 2001-12-21 | 2002-12-23 | レプチンタンパク質 |
| JP2003556443A Abandoned JP2005528086A (ja) | 2001-12-21 | 2002-12-23 | 分泌タンパク質 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US20040106778A1 (cg-RX-API-DMAC7.html) |
| EP (3) | EP1468018A2 (cg-RX-API-DMAC7.html) |
| JP (3) | JP2005532034A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20040086247A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1620467A (cg-RX-API-DMAC7.html) |
| AU (3) | AU2002356317A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR0215284A (cg-RX-API-DMAC7.html) |
| CA (3) | CA2470666A1 (cg-RX-API-DMAC7.html) |
| EA (1) | EA007813B1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB0130720D0 (cg-RX-API-DMAC7.html) |
| IL (1) | IL162598A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA04006049A (cg-RX-API-DMAC7.html) |
| WO (3) | WO2003054012A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003298344A1 (en) * | 2002-12-04 | 2004-06-23 | Laboratoires Serono Sa | Novel ifngamma-like polypeptides |
| GB0314456D0 (en) * | 2003-06-20 | 2003-07-23 | Ares Trading Sa | Interferon gamma-like protein |
| CA2527091A1 (en) * | 2003-06-20 | 2004-12-29 | Ares Trading S.A. | Interferon gamma-like protein |
| AU2004269927B2 (en) * | 2003-09-08 | 2009-09-17 | Merck Serono Sa | Treatment of fibrotic disease |
| US8778880B2 (en) * | 2004-02-02 | 2014-07-15 | Ambrx, Inc. | Human growth hormone modified at position 35 |
| ZA200606224B (en) * | 2004-02-02 | 2007-11-28 | Ambrx Inc | Modified human growth hormone polypeptides and their uses |
| US20050260155A1 (en) * | 2004-05-18 | 2005-11-24 | Gopala Kovvali | Compositions and methods for treatment of ulcerative colitis |
| CA2603452A1 (en) * | 2005-04-04 | 2006-10-12 | Julius-Maximillians-Universitat Wurzburg | Tripeptides that down regulate the activity of plasma membrane transporters including sodium-d-glucose cotransporter sglt1 |
| US7943328B1 (en) | 2006-03-03 | 2011-05-17 | Prometheus Laboratories Inc. | Method and system for assisting in diagnosing irritable bowel syndrome |
| US8432899B2 (en) | 2007-02-22 | 2013-04-30 | Aylus Networks, Inc. | Systems and methods for enabling IP signaling in wireless networks |
| US9026117B2 (en) | 2006-05-16 | 2015-05-05 | Aylus Networks, Inc. | Systems and methods for real-time cellular-to-internet video transfer |
| US20080085524A1 (en) * | 2006-08-15 | 2008-04-10 | Prometheus Laboratories Inc. | Methods for diagnosing irritable bowel syndrome |
| US20100094560A1 (en) * | 2006-08-15 | 2010-04-15 | Prometheus Laboratories Inc. | Methods for diagnosing irritable bowel syndrome |
| EP2281199B1 (en) * | 2008-06-04 | 2017-03-01 | KCI Licensing, Inc. | Detecting infection in reduced pressure wound treatment |
| HK1201176A1 (en) * | 2011-10-20 | 2015-08-28 | Neostem Oncology, Llc | Antigen presenting cancer vaccine |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6245966B1 (en) * | 1998-07-14 | 2001-06-12 | University Technology Corporation | Adenoviral mediated gene transfer into lymphocytes |
| MXPA01012384A (es) * | 1999-06-01 | 2002-09-02 | Zymogenetics Inc | Proteina zsig81 con haz de cuatro helices. |
| AU2608201A (en) * | 1999-12-30 | 2001-07-16 | Corixa Corporation | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| WO2001051510A2 (en) * | 2000-01-10 | 2001-07-19 | Maxygen Holdings Ltd | G-csf conjugates |
| US20020048763A1 (en) * | 2000-02-04 | 2002-04-25 | Penn Sharron Gaynor | Human genome-derived single exon nucleic acid probes useful for gene expression analysis |
| US6436703B1 (en) * | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
| AU2001280889A1 (en) * | 2000-07-31 | 2002-02-13 | Gene Logic, Inc. | Molecular toxicology modeling |
| WO2004094713A2 (en) * | 2003-04-16 | 2004-11-04 | Applied Dna Sciences, Inc. | System and method for marking textiles with nucleic acids |
| GB0314456D0 (en) * | 2003-06-20 | 2003-07-23 | Ares Trading Sa | Interferon gamma-like protein |
-
2001
- 2001-12-21 GB GBGB0130720.6A patent/GB0130720D0/en not_active Ceased
-
2002
- 2002-12-23 WO PCT/GB2002/005885 patent/WO2003054012A2/en not_active Ceased
- 2002-12-23 AU AU2002356317A patent/AU2002356317A1/en not_active Abandoned
- 2002-12-23 WO PCT/GB2002/005890 patent/WO2003055912A2/en not_active Ceased
- 2002-12-23 EP EP02788242A patent/EP1468018A2/en not_active Withdrawn
- 2002-12-23 JP JP2003556442A patent/JP2005532034A/ja not_active Abandoned
- 2002-12-23 AU AU2002353224A patent/AU2002353224B2/en not_active Expired - Fee Related
- 2002-12-23 EP EP02805839A patent/EP1468019A2/en not_active Withdrawn
- 2002-12-23 CA CA002470666A patent/CA2470666A1/en not_active Abandoned
- 2002-12-23 JP JP2003554728A patent/JP2005528083A/ja not_active Abandoned
- 2002-12-23 EA EA200400812A patent/EA007813B1/ru not_active IP Right Cessation
- 2002-12-23 AU AU2002353227A patent/AU2002353227A1/en not_active Abandoned
- 2002-12-23 EP EP02788245A patent/EP1463756A2/en not_active Withdrawn
- 2002-12-23 JP JP2003556443A patent/JP2005528086A/ja not_active Abandoned
- 2002-12-23 MX MXPA04006049A patent/MXPA04006049A/es unknown
- 2002-12-23 CA CA002470594A patent/CA2470594A1/en not_active Abandoned
- 2002-12-23 IL IL16259802A patent/IL162598A0/xx unknown
- 2002-12-23 CA CA002471306A patent/CA2471306A1/en not_active Abandoned
- 2002-12-23 WO PCT/GB2002/005914 patent/WO2003055913A2/en not_active Ceased
- 2002-12-23 CN CNA028282752A patent/CN1620467A/zh active Pending
- 2002-12-23 KR KR10-2004-7009758A patent/KR20040086247A/ko not_active Ceased
- 2002-12-23 BR BR0215284-3A patent/BR0215284A/pt not_active IP Right Cessation
-
2003
- 2003-06-20 US US10/600,790 patent/US20040106778A1/en not_active Abandoned
-
2004
- 2004-06-21 US US10/873,332 patent/US20050042731A1/en not_active Abandoned
- 2004-06-21 US US10/872,598 patent/US20050106679A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005532034A5 (cg-RX-API-DMAC7.html) | ||
| JP2005528086A5 (cg-RX-API-DMAC7.html) | ||
| JP2005528083A5 (cg-RX-API-DMAC7.html) | ||
| EP2883954B1 (en) | Peptide library and use thereof | |
| JP2011231085A (ja) | 環状ペプチド | |
| CN101148666B (zh) | 一组与人乳腺癌组织高特异性和高亲和力的核酸适配子及其制备方法与应用 | |
| US20200247855A1 (en) | Therapy and diagnostics | |
| CN118638796A (zh) | 骨关节炎早期生物标志物软骨酸性蛋白靶向适配体及其构建方法 | |
| WO2018031897A1 (en) | Compositions and methods for analyzing nucleic acids associated with an analyte | |
| JP2007526759A5 (cg-RX-API-DMAC7.html) | ||
| WO2012105616A1 (ja) | ペプチド・ライブラリー | |
| US20110091457A1 (en) | Method for prognosticating the clinical response of a patient to b-lymphocyte inhibiting or depleting therapy | |
| Li et al. | Recent developments in affinity-based selection of aptamers for binding disease-related protein targets | |
| KR101923198B1 (ko) | Tb7.7에 특이적으로 결합하는 dna 압타머 및 이의 용도 | |
| KR101513766B1 (ko) | 알파태아단백질에 특이적으로 결합하는 ｄｎａ 앱타머 및 이의 용도 | |
| CN109957027A (zh) | 一组着丝粒蛋白f（cenpf）分片段抗原及其应用 | |
| CN118459550A (zh) | 一种小分子化合物及其制备方法和应用 | |
| CN102127561A (zh) | 重组荧光双杂交酵母及其检测方法与应用 | |
| CN104650214B (zh) | 肺动脉高压致病基因acvrl1突变位点及其应用 | |
| JP2006526386A5 (cg-RX-API-DMAC7.html) | ||
| CN113234134B (zh) | 一种远端关节挛缩综合症致病基因myh3及其用途 | |
| JP2005500012A5 (cg-RX-API-DMAC7.html) | ||
| CN111440783B (zh) | 一种caii的突变体及其应用 | |
| JP2006516888A5 (cg-RX-API-DMAC7.html) | ||
| CN118955674A (zh) | 一种新型微肽hmbj及其应用 |